Yüklüyor......
Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in Type 2 diabetes
The antihyperglycemic agent linagliptin, a dipeptidyl peptidase-4 (DPP-IV) inhibitor, has been shown to reduce inflammation and improve endothelial cell function. In this study, we hypothesized that DPP-IV inhibition with linagliptin would improve impaired cerebral perfusion in diabetic rats, as wel...
Kaydedildi:
| Yayımlandı: | Am J Physiol Regul Integr Comp Physiol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Physiological Society
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5142225/ https://ncbi.nlm.nih.gov/pubmed/27357799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpregu.00057.2016 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|